Rep. Pramila Jayapal, D-Wash., said the White House is supportive of proposals for sweeping Medicare expansion that would broaden coverage and lower the eligibility age to 60, but only if lawmakers ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

Orforglipron is Lilly’s oral GLP-1 in phase 3 development as a treatment for diabetes and obesity. The FDA is expected to approve the drug in March 2026. Lilly’s November news release states that the ...

(Reuters) — Eli Lilly and Novo Nordisk are expected to announce deals with the Trump administration to cut prices of their weight-loss drugs in exchange for Medicare coverage, a White House source ...

Novo Nordisk’s Ozempic, Astellas’ Xtandi and Pfizer’s Ibrance are among the 15 drugs that have a new fair maximum price.

The Trump administration is touting $12 billion in federal savings in Medicare’s second year of drug price negotiations.

The United Kingdom agreed to pay more for prescription drugs in a trade deal announced with the U.S. on Monday that will ...

The White House announced that new partnerships with drugmakers will let people buy popular GLP-1 drugs for as little as $350 a month. The White House also announced that Medicare will begin covering ...

The reopening of the federal government has brought relief for skilled nursing providers, though key questions about reimbursement and regulatory implications still remain.

Keep an eye on Novo Nordisk: Trump struck a deal with drugmakers Eli Lilly and Novo Nordisk earlier this month for their weight-loss drugs, which will allow Medicare to pay $245 a month for Ozempic, ...